Skip to Content


In the US, Rivastigmine (rivastigmine systemic) is a member of the drug class cholinesterase inhibitors and is used to treat Alzheimer's Disease, Lewy Body Dementia and Parkinson's Disease.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Cholinesterase inhibitor (parasympathomimetic agent, indirect acting)

Treatment of Alzheimer's disease

Chemical Name

(-)-m-[(S)-1-(Dimetylamino)etyl]phenyl etylmetylcarbamate (WHO)

Foreign Names

  • Rivastigminum (Latin)
  • Rivastigmin (German)
  • Rivastigmine (French)
  • Rivastigmina (Spanish)

Generic Names

  • Rivastigmine (OS: BAN, DCF, USAN, JAN)
  • ENA 713 (IS: Sandoz)
  • SDZ 212-713 (IS: Sandoz)
  • SDZ-ENA 713 (IS: Sandoz)
  • Rivastigmin (PH: Ph. Eur. 8)
  • Rivastigmine (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Rivastigminum (PH: Ph. Eur. 8)
  • Rivastigmine Hydrogen Tartrate (OS: BANM)
  • Rivastigmin hydrogentartrat (PH: Ph. Eur. 8)
  • Rivastigmine (tartrate de) (PH: Ph. Eur. 8)
  • Rivastigmine Hydrogen Tartrate (PH: BP 2016)
  • Rivastigmine hydrogen tartrate (PH: Ph. Eur. 8)
  • Rivastigmine Tartrate (PH: USP 38)
  • Rivastigmini hydrogenotartras (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.